Danish guideline implementation
Danish guideline implementation has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Sep 7, 2026: “Nationwide LDL-C goal attainment in high-risk and very-high-risk patients in Denmark: real-world lipid management and simulated impact of guideline implementation”.
1 paper studies it2 findingsUpdated
See all 1 papers on Danish guideline implementation
- Humans1
What did studies of Danish guideline implementation find?
2Studies of Danish guideline implementation measured 2 outcomes: cardiovascular death and LDL-C goal attainment.
Cardiovascular death
downin silico1
1 study
Cardiovascular death
downin silico1
Danish guideline implementation prevents cardiovascular death in silico (compared with real-world outcomes, simulated) (196 cardiovascular deaths annually).
“implementation of the Danish guideline could annually prevent 589 strokes, 491 myocardial infarctions, 581 revascularisations and 196 cardiovascular deaths”
In silicocompared with real-world outcomes, simulated
Open heart
LDL-C goal attainment
upin silico1
1 study
LDL-C goal attainment
upin silico1
Danish guideline implementation increases LDL-C goal attainment in silico (simulated optimal implementation) (to 91.9% primary and 63.5% secondary prevention, from 39.8% primary observed).
“With optimal implementation, attainment increased to 91.9% (primary) and 63.5% (secondary) under the Danish guideline”
In silicosimulated optimal implementation
Open heart